Vimeo
LinkedIn
Instagram
Share |

Campden Wealth

September 17, 2021

More resilient first-generation wealth holders in China, lagging behind global peers in formalising their inheritance plans, are opening family offices to train and support their solitary “ill-equipped” next generation successors in wealth preservation, investments and philanthropy.

More resilient first-generation wealth holders in China, lagging behind global peers in formalising their inheritance plans, are opening family offices to train and support their solitary “ill-equipped” next generation successors in wealth preservation, investments and philanthropy.

September 15, 2021

Wealthy families, foundations and individuals with an estimated total net worth of $328 billion are accelerating their interests in sustainable and impact investing to an unprecedented level, propelled by the Covid-19 pandemic and climate crisis.

Wealthy families, foundations and individuals with an estimated total net worth of $328 billion are accelerating their interests in sustainable and impact investing to an unprecedented level, propelled by the Covid-19 pandemic and climate crisis.

An overwhelming majority surveyed by Campden Wealth in 2021 said the transition to net-zero emission was the “greatest commercial opportunity of our age”. Investors were aligning their portfolios with their climate-conscious commitments and the United Nations’ Sustainable Development Goals.

September 14, 2021

The chairman of Supernova Invest, the pioneer and leader of deep tech investment in France, will discuss how investors, families and companies can achieve their goals at the in-person MedTech Investing Europe Forum.

The chairman of Supernova Invest, the pioneer and leader of deep tech investment in France, will discuss how investors, families and companies can achieve their goals at the in-person MedTech Investing Europe Forum.

September 14, 2021

Picture yourself as a successor, recently arrived in a foreign market with no clear job description, no clarity on why you are there and a suspicious local management team. Your brief is to 'Find your own way and make a difference' in a company with €1 billion plus sales and a track record of minimum active family involvement.

Picture yourself as a successor, recently arrived in a foreign market with no clear job description, no clarity on why you are there and a suspicious local management team. Your brief is to 'Find your own way and make a difference' in a company with €1 billion plus sales and a track record of minimum active family involvement.

August 13, 2021

Cutting-edge venture stage innovations for chronic diseases with billion-dollar market potential will be presented to private investors at the Campden Wealth 31st MedTech Investing Europe Forum on 21-22 September, 2021.

Cutting-edge venture stage innovations for chronic diseases with billion-dollar market potential will be presented to private investors at the Campden Wealth 31st MedTech Investing Europe Forum on 21-22 September, 2021.

August 9, 2021

Do you know what your value to the family company as a successor is? If you are considering joining, do you know under what conditions your value might be at its maximum? Are these questions important?

Do you know what your value to the family company as a successor is? If you are considering joining, do you know under what conditions your value might be at its maximum? Are these questions important?

July 27, 2021

Say Flanders, think research and technology. Belgium’s northern region is a well-known beacon of innovation. Its companies, research centres and knowledge institutions are at the basis of ground-breaking solutions in niches like digital, health and climate tech.

Say Flanders, think research and technology. Belgium’s northern region is a well-known beacon of innovation. Its companies, research centres and knowledge institutions are at the basis of ground-breaking solutions in niches like digital, health and climate tech.

Through its worldwide Science and Technology Offices, Flanders Investment and Trade helps Flanders build bridges of knowhow and innovative strength across the globe—and you can reap the rewards, too.

July 21, 2021

Why should a family business recruit non-family talent, and in particular a non-executive director? The answer lies in three areas—fresh perspectives and breadth of experience, independent oversight and constructive challenge, and performance.

Why should a family business recruit non-family talent, and in particular a non-executive director (NED)? The answer lies in three areas—fresh perspectives and breadth of experience, independent oversight and constructive challenge, and performance.

Independent research commissioned by the Institute of Directors found that the NED contribution added value to the firm with most believing the NED role improved profitability.

July 14, 2021

The medical technology industry is enjoying record levels of M&A activity. Deloitte’s 2020 MedTech review identified a 24% increase in transactions in Western Europe, with strong focus on diagnostics, orthopaedics and data driven innovation.

The medical technology industry is enjoying record levels of M&A activity. Deloitte’s 2020 MedTech review identified a 24% increase in transactions in Western Europe, with strong focus on diagnostics, orthopaedics and data driven innovation.

For many investors the strong growth prospects, resilient valuations and defensive nature of healthcare investments make this a very attractive market. Evaluate MedTech calculates $6 billion of venture financing was invested in 2019 and 2020, slightly down from the 2017 high of $7.8 billion.

Click here >>
Close